TheProfitWatch

PRME - Prime Medicine, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
6.01 0.38 (6.32%) --- --- 0.01 (0.16%) 0.19 (3.16%) 0.18 (2.91%) 0.01 (0.14%) 0.01 (0.14%)

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.41
Diluted EPS:
-0.41
Basic P/E:
-15.5854
Diluted P/E:
-15.5854
RSI(14) 1m:
100.0
VWAP:
6.39
RVol:

Events

Period Kind Movement Occurred At

Related News